Selective serotonin reuptake inhibitors and preeclampsia: “First, do no harm”!
- 1 December 2022
- journal article
- letter
- Published by Elsevier BV in Pregnancy Hypertension
- Vol. 30, 145
- https://doi.org/10.1016/j.preghy.2022.10.002
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Selective serotonin reuptake inhibitors and preeclampsia: A quality assessment and meta-analysisPregnancy Hypertension, 2022
- The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analysesWorld Psychiatry, 2022
- Antidepressants are not safe during pregnancy and in women of child‐bearing ageBritish Journal of Clinical Pharmacology, 2021
- Maintenance or Discontinuation of Antidepressants in Primary CareThe New England Journal of Medicine, 2021
- Prenatal Selective Serotonin Reuptake Inhibitor Use and Associated Risk for Gestational Hypertension and Preeclampsia: A Meta-Analysis of Cohort StudiesJournal of Women's Health, 2018